Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 14,855 | 11,304 | 10,177 | 9,250 | 7,871 |
| Operating Income | -14,855 | -11,304 | -10,177 | -9,250 | -7,871 |
| Interest Expense | 2,039 | 1,739 | 1,510 | 1,354 | 1,215 |
| Other Income | 1,127 | 329 | 342 | 1,133 | 901 |
| Pre-tax Income | -15,767 | -12,714 | -11,345 | -9,471 | -8,185 |
| Net Income Continuous | -15,767 | -12,714 | -11,345 | -9,471 | -8,185 |
| Net Income | $-15,767 | $-12,714 | $-11,345 | $-9,471 | $-8,185 |
| EPS Basic Total Ops | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 |
| EPS Basic Continuous Ops | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 |
| EPS Diluted Total Ops | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 |
| EPS Diluted Continuous Ops | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 |
| EBITDA(a) | $-14,855 | $-11,304 | $-10,177 | $-9,250 | $-7,871 |